Kelly Seaton

23PUBLICATIONS
159CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsCharacterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 06, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Jul 13, 2025
Prior human endemic coronavirus exposure does not affect humoral responses to SARS-CoV-2 protein vaccines.

Guy de Bruyn, Haritha Adhikarla, Caroline K Brackett

|Apr 24, 2025
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery.

Dieter Mielke, Shuying Sue Li, Daniel J Schuster

|Nov 14, 2024
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.

Lin Lin, Rachel L Spreng, Kelly E Seaton

|Sep 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Vimla Naicker, Fatima Laher, Linda-Gail Bekker

Pageof 4

Frequent Collaborators

10 joint publications

Georgia D Tomaras

9 joint publications

David Montefiori

6 joint publications

Lawrence Corey

6 joint publications

Lindsay N Carpp